Announcements Trials
Browse Landscape

Status

Completed 2Unknown 1Active not recruiting 1

Sponsor Class

OTHER 2INDUSTRY 2

Study Type

Observational 4Interventional 3

Sponsor

Conditions

Breast Neoplasms 2936Neoplasms 2634Lung Neoplasms 1371Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1080Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 496Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 423Neoplasm Metastasis 418Brain Neoplasms 405Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 313Recurrence 298Disease 275

Interventions

Diagnostic Tests, Routine 2Longitudinal Studies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Hereditary Cancer × Clear all
NCT06157801 2026-03-04

Evaluation of Hereditary Cancer Educational Videos

M.D. Anderson Cancer Center

Active not recruiting
43 enrolled

Hereditary Cancer

NCT03319290 2019-01-23

Increase Surveillance for Breast and Ovarian Cancers, Also to Determine Targeted Risk-reducing and Preventative Strategies

Data Collection Analysis Business Management

Unknown
2,000 enrolled

Hereditary Cancer

NCT03067389 2019-01-15

Combined Breast Cancer Risk Study

Myriad Genetic Laboratories, Inc.

Completed
553 enrolled

Hereditary Cancer

NCT03081455 2017-08-08

Impact of a Process Intervention on Screening and Testing Outcomes for Common Hereditary Cancer Syndromes

Myriad Genetic Laboratories, Inc.

Completed
145 enrolled

Hereditary Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡